APLP2 and cancer: Given that APLP2 expression is altered in many cancer cells and APLP2 expression is correlated with poor outcomes, APLP2-targeted therapy might have potential to benefit cancer therapy through immune-mediated, as well as non-immune-mediated, mechanisms.